Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : MDA - Market Direction Analysis -- Ignore unavailable to you. Want to Upgrade?

To: Casaubon who wrote (55403)	6/26/2000 10:53:00 PM
From: Haim R. Branisteanu	Read Replies (2) \| Respond to of 99985

Casaubon, I have a very close friend who is a respectable Biotech Professor and head of a researchers team in the field of cancer at Memorial Sloan Kettering in NYC, and I learned a thing or two about the real research and pure stock hype and GREED. As a result of such hype I was lured in hopping to put my terminally ill father on a test program which I hoped may prolong his life, only to find out that the BioTech company was not interested because my father age and the advanced stage of the cancer, resulting in the possibility that he may "destroy" their statistics. I do not want to go forth on this painful experience but IMHO many Biotech Cieftains are no better than Mother F^&^ and horse traders that you have also with the big drug companies. So much for those companies, their only motive is GREED not science. Science is done in lots of other places but not those F^&*^% start ups who do nothing more than steal a concept and then commercialize it. Later I found out that the rumor of cure was false and they are very early in clinical trials and the stock droped $20 or $30 So please do not post to me about the greatness of Biotech companies........ it is to personal and to painful!!!! (I know you work for one) Thank you Haim

To: Casaubon who wrote (55403)	6/26/2000 11:23:00 PM
From: Les H	Read Replies (1) \| Respond to of 99985

The drugs with poor outcomes and side effects became more common only with the recent fasttrack policy at the FDA since many patients couldn't wait for breakthroughs in AIDs, cancers, etc.

To: Casaubon who wrote (55403)	6/27/2000 12:33:00 AM
From: el paradisio	Respond to of 99985

Casaubon, not all is the truth about the biotech and pharma. Truth,innovative drugs,particulary useful in immunological diseases, and viral infections( like monoclonal) Only this one, designed against a protein can be less error prone. Not truth,<old compounds pulled from the shelves>. If you have many years of experience with the drugs,I think,you agree with me, that free side effect drug... does not exist and only after 3 years of statistics,we can say if the drug is safe in use or not. How many old drugs,like Zocor,Tylenol,Tagamet,Diabeta are on the shelf....and how many of the recent ones were removed from the shelves. el